Prepared omadacycline for injection: Nine-day stability and sterility in an elastomeric pump
Objective: To investigate compatibility, stability, and microbiologic risk of omadacycline 1 mg/mL when prepared in an elastomeric infusion pump and stored under refrigeration for 9 days based upon requests for information from healthcare providers. Methods: Omadacycline was reconstituted to 1 mg/mL...
Main Authors: | Jason Bower, Kelly Wright, Jason Burdette |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-11-01
|
Series: | SAGE Open Medicine |
Online Access: | https://doi.org/10.1177/20503121221135568 |
Similar Items
-
Stability of Antimicrobials in Elastomeric Pumps: A Systematic Review
by: Beatriz Fernández-Rubio, et al.
Published: (2021-12-01) -
Application of omadacycline in the treatment of severe Japanese spotted fever
by: Wei-Xin Xu, et al.
Published: (2024-03-01) -
Omadacycline use in a traveler with severe Legionella pneumonia
by: Jianfeng Wang, et al.
Published: (2023-11-01) -
Omadacycline Is Highly Active In Vitro against Mycoplasma genitalium
by: Ken B. Waites, et al.
Published: (2022-12-01) -
Activity of omadacycline in vitro against Clostridioides difficile and preliminary efficacy assessment in a hamster model of C. difficile-associated diarrhoea
by: Raina Gay Leahy, et al.
Published: (2022-09-01)